Trexquant Investment LP Novo Cure LTD Transaction History

Trexquant Investment LP

$7.59 Billion
Q3 2024

A detailed history of Trexquant Investment LP transactions in Novo Cure LTD stock. As of the latest transaction made, Trexquant Investment LP holds 113,849 shares of NVCR stock, worth $3.51 Million. This represents 0.02% of its overall portfolio holdings.

Number of Shares

113,849

Previous 185,936 38.77%

Holding current value

$3.51 Million

Previous $3.19 Million 44.14%

% of portfolio

0.02%

Previous 0.05%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$15.61 - $23.34 $1.13 Million - $1.68 Million	-72,087 Reduced 38.77%	113,849 $1.78 Million
Q2 2024 Aug 13, 2024	SELL	$11.83 - $24.05 $1.09 Million - $2.22 Million	-92,402 Reduced 33.2%	185,936 $3.19 Million
Q1 2024 May 14, 2024	BUY	$12.42 - $17.29 $646,063 - $899,391	52,018 Added 22.98%	278,338 $4.35 Million
Q4 2023 Feb 09, 2024	BUY	$11.13 - $15.78 $1.78 Million - $2.52 Million	159,755 Added 240.0%	226,320 $3.38 Million
Q3 2023 Nov 13, 2023	BUY	$16.15 - $42.35 $1.08 Million - $2.82 Million	66,565 New	66,565 $1.08 Million
Q1 2023 May 15, 2023	SELL	$56.44 - $118.81 $15,351 - $32,316	-272 Reduced 6.39%	3,986 $239,000
Q4 2022 Feb 13, 2023	BUY	$63.98 - $85.37 $272,426 - $363,505	4,258 New	4,258 $312,000
Q2 2022 Aug 11, 2022	SELL	$56.6 - $89.9 $387,144 - $614,916	-6,840 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$60.15 - $84.52 $1.38 Million - $1.94 Million	-23,011 Reduced 77.09%	6,840 $567,000
Q4 2021 Feb 14, 2022	BUY	$75.08 - $121.99 $1.26 Million - $2.04 Million	16,763 Added 128.08%	29,851 $2.24 Million
Q3 2021 Nov 12, 2021	BUY	$116.17 - $194.55 $1.52 Million - $2.55 Million	13,088 New	13,088 $1.52 Million
Q2 2021 Aug 12, 2021	SELL	$130.4 - $225.58 $1.78 Million - $3.09 Million	-13,683 Closed	0 $0
Q1 2021 May 13, 2021	BUY	$124.11 - $190.17 $1.7 Million - $2.6 Million	13,683 New	13,683 $1.81 Million
Q4 2020 Feb 11, 2021	SELL	$112.16 - $174.14 $1.7 Million - $2.64 Million	-15,147 Closed	0 $0
Q3 2020 Nov 06, 2020	SELL	$58.05 - $111.31 $342,785 - $657,285	-5,905 Reduced 28.05%	15,147 $1.69 Million
Q2 2020 Aug 07, 2020	BUY	$57.2 - $74.41 $546,488 - $710,913	9,554 Added 83.09%	21,052 $1.25 Million
Q1 2020 May 08, 2020	BUY	$57.05 - $95.75 $655,960 - $1.1 Million	11,498 New	11,498 $774,000
Q4 2019 Feb 12, 2020	SELL	$68.3 - $93.8 $1.64 Million - $2.26 Million	-24,067 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$61.86 - $97.8 $1.49 Million - $2.35 Million	24,067 New	24,067 $1.8 Million
Q2 2019 Aug 09, 2019	SELL	$42.22 - $63.23 $1.37 Million - $2.05 Million	-32,438 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$31.96 - $56.12 $808,907 - $1.42 Million	25,310 Added 355.08%	32,438 $1.56 Million
Q4 2018 Feb 13, 2019	BUY	$28.72 - $52.63 $204,716 - $375,146	7,128 New	7,128 $239,000
Q1 2018 May 03, 2018	SELL	$19.3 - $23.65 $495,006 - $606,575	-25,648 Closed	0 $0
Q4 2017 Feb 09, 2018	BUY	$16.3 - $21.9 $243,815 - $327,580	14,958 Added 139.93%	25,648 $518,000
Q3 2017 Nov 09, 2017	BUY	$18.05 - $21.75 $192,954 - $232,507	10,690	10,690 $212,000

Others Institutions Holding NVCR

# of Institutions

263

Shares Held

77M

Call Options Held

1.17M

Put Options Held

318K

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $3.23B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Account

Trexquant Investment LP Novo Cure LTD Transaction History